Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]

Neoadjuvant nivolumab for resectable lung cancer

Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA

Neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )

Biomarkers of pembrolizumab response in head and neck cancer

Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA

Biomarkers of pembrolizumab response in head and neck cancer ( Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA )

Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy

Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA

Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy ( Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA )

First-in-human trial results of RET targeted BLU-667

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA

First-in-human trial results of RET targeted BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )

Treating RET alterations with novel therapy BLU-667

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA

Treating RET alterations with novel therapy BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )

Tandem duplications in triple negative breast cancer

Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA

Tandem duplications in triple negative breast cancer ( Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA )

Increasing diversity through the NCI SBIR development centre

Dr Christie Canaria - National Cancer Institute, Rockville, USA

Increasing diversity through the NCI SBIR development centre ( Dr Christie Canaria - National Cancer Institute, Rockville, USA )

The importance of online patient groups and 'The ROS1ders'

Janet Freeman-Daily - The ROS1ders

The importance of online patient groups and 'The ROS1ders' ( Janet Freeman-Daily - The ROS1ders )

Effects of dasatinib on xenograft lung tumour models with YES1 overexpression

Dr Irati Garmendia - University of Navarra, Pamplona, Spain

Effects of dasatinib on xenograft lung tumour models with YES1 overexpression ( Dr Irati Garmendia - University of Navarra, Pamplona, Spain )

Analysis tools for NCI genomic databases

Dr Jean Claude Zenklusen - National Cancer Institute, Rockville, USA

Analysis tools for NCI genomic databases ( Dr Jean Claude Zenklusen - National Cancer Institute, Rockville, USA )

Results from GOBACK: Non-chromosomal birth defects linked with cancer

Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA

Results from GOBACK: Non-chromosomal birth defects linked with cancer ( Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA )

A link between non-chromosomal birth defects and cancer

Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA

A link between non-chromosomal birth defects and cancer ( Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA )

More from ecancer